CAS No.763114-26-7 Pharmaceutical Intermediates
introduce
Olaparib intermediates are chemical compounds necessary for the synthesis of Olaparib, a potent poly(ADP-ribose) polymerase (PARP) inhibitor. These intermediates play a key role in the pharmaceutical industry, particularly in the development of targeted therapies for cancers associated with BRCA1 and BRCA2 mutations. By facilitating the efficient production of Olaparib, these intermediates help drive the development of innovative cancer treatments that improve patient outcomes.
Physical and chemical properties
- Molecular formula: C16H11FN2O3.
- Molecular weight: 298.27.
- Appearance: Usually white powder.
- Solubility: Olaparib intermediates are generally soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, and have different solubility in water, which is beneficial for various formulation processes.
- Melting Point: Melting points vary depending on the specific intermediate and indicate stability under standard laboratory conditions.
- Chemical Stability: These intermediates exhibit good stability under recommended storage conditions, ensuring their effectiveness in drug formulations.
- Essential for Synthesis: These intermediates are essential for the efficient synthesis of Olaparib, allowing pharmaceutical companies to efficiently produce this important cancer treatment.
- High reactivity: The chemical structures of these intermediates allow for efficient reactions, thus facilitating the synthesis of olaparib in high yields.
- Quality Assurance: Olaparib intermediates are produced under strict quality control measures and comply with international pharmaceutical standards to ensure safety and efficacy.
- Cost Effective: Our integrated manufacturing and trading model enables us to offer competitive prices without compromising quality.
- Global Availability: With a strong distribution network, we ensure timely supply of Olaparib intermediates to customers around the world.
- Synthesis of Olaparib: These intermediates are essential for the production of Olaparib, which is used to treat various cancers, particularly those associated with BRCA mutations.
- Research and Development: Their unique properties make them valuable compounds for research laboratories engaged in drug discovery and development, particularly in oncology.
- Formulation Development: Olaparib intermediates can be used to formulate various dosage forms to improve the bioavailability and efficacy of the final product.
In conclusion,olaparib intermediates are an essential component in the synthesis of a leading cancer therapy. Their unique properties, combined with our commitment to quality and reliability, make them an ideal choice for pharmaceutical manufacturers and researchers. By choosing Olaparib intermediates, you are investing in essential building blocks that can drive innovation in cancer treatment.